Dr Reddys Laboratories Share Price Today - Live Blog for October 07, 2025

After a notable 0.05% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,250.20. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.10% upswing, and it's currently trading at ₹1,249.90 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd witnessed a -0.03% decrease in its share price, and it is currently trading at ₹1,248.60. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.3400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

With a remarkable 0.20% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,247.90. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.3400, while the industry's PE ratio is 34.3345.

Dr Reddys Laboratories Ltd's share price has fallen by -0.02%, a situation worth noting. At present, the stock is trading at ₹1,247.70. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.3400, while the industry PE ratio is 34.3345.

With a -0.15% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,248.10. Investors should examine the factors driving this decline. The stock's PE ratio is 18.3400, whereas the industry PE ratio stands at 34.3345.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.20%, reaching the current market price of ₹1,249.70. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd's share price has fallen by -0.01%, a situation worth noting. At present, the stock is trading at ₹1,247.20. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.3400, while the industry PE ratio is 34.3345.

Dr Reddys Laboratories Ltd's shares experienced a 0.24% uptick, and they are currently valued at ₹1,248.00, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd observed a -0.29% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,245.00. The stock has a PE ratio of 18.3400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's stock price surged by 0.12%, reaching the current market value of ₹1,249.65 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd's share price has fallen by -0.10%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,248.15, and market participants are assessing the implications. The stock has a PE ratio of 18.3400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has fallen by -0.10%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,248.15, and market participants are assessing the implications. The stock has a PE ratio of 18.3400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd share price has declined by -0.16%, and it's currently trading at ₹1,249.35. The stock maintains a PE of 18.3400, while the industry PE is 34.3345, prompting discussions about its valuation.

With a -0.16% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,249.35. Investors should examine the factors driving this decline. The stock's PE ratio is 18.3400, whereas the industry PE ratio stands at 34.3345.

With a -0.16% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,249.35. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.3400, while the industry PE is 34.3345.

With a remarkable 0.02% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,254.30. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.3400, while the industry's PE ratio is 34.3345.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.02% recently. As of now, this stock is actively trading at a current market price of ₹1,254.30 per share, attracting attention from investors.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.03%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,254.30 per share.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.14%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,252.20 per share.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.25%, signalling a challenging period. Currently trading at ₹1,250.00, this stock has caught the eye of bargain hunters, who may be considering their entry points.

With a -0.01% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,253.10. The stock is currently trading at a PE of 18.3400, while the industry PE is 34.3345, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd experienced a -0.01% dip in its share price and is currently trading at ₹1,253.10. The stock has a PE ratio of 18.3400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.01%, reaching a current market price of ₹1,252.75. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd shares saw a -0.02% decrease, reaching a current market price of ₹1,252.85. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.3400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price rallied by 0.13%, reaching the current market price of ₹1,253.70. This surge is indicative of the stock's recent positive performance.

Demonstrating a commendable 0.09% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,252.00. In terms of valuation, the stock maintains a PE ratio of 18.3400, while the industry PE ratio stands at 34.3345.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.01% drop, and it's now trading at ₹1,250.85 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

After a -0.27% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,251.00. The stock has a PE ratio of 18.3400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

With a remarkable 0.48% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,254.55. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.3400, while the industry's PE ratio is 34.3345.